$3.14
0.05 (+1.62%)
Cleveland BioLabs, Inc. (NASDAQ:CBLI)
CAPS Rating:
The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.
RSS Headlines
Fool UK